Skip to content

Interventional Glaucoma

Challenging the Current Standard of Care

Is the standard of care evolving with Interventional Glaucoma (IG)?

IG is a Mindset

  • Proactive vs. reactive iconProactive vs reactive
  • Early predictive diagnostics iconEarly predictive diagnostics
  • Active monitoring iconActive monitoring
  • Early procedural intervention iconEarly procedural intervention
  • Adherence and risk iconAddress adherence and risk

The Current Reality

Prescription eyedrops are associated with limitations relating to non-adherence, adverse events, and drug delivery inefficiencies.1

  • >90%of patients are non-adherent with their prescription eye drops1
  • ~50%of patients stop taking their medications within 6 months1

THE POTENTIAL PARADIGM SHIFT WITH IG

A critical component of IG is a long duration procedural pharmaceutical—a unique technology that delivers continuous prostaglandin analog therapy.

  • 24/7patient adherence with drug elution
  • HELPS REDUCEthe burden of daily administration and patient difficulty using eye drops

DISCOVER
iDOSE TR

 Learn More

Ready to hear more?

Contact a representative to request more info.

  1. Nordstrom BL, et al. Persistence and adherence with topical glaucoma therapy. Am J Ophthalmol. 2005;140(4): 598-606. doi:10.1016/j.ajo.2005.04.051

Important Safety Information

Dosage And Administration

For ophthalmic intracameral administration. The intracameral administration should be carried out under standard aseptic conditions.

Contraindications

iDose TR is contraindicated in patients with active or suspected ocular or periocular infections, patients with corneal endothelial cell dystrophy (e.g., Fuch’s Dystrophy, corneal guttatae), patients with prior corneal transplantation, or endothelial cell transplants (e.g., Descemet’s Stripping Automated Endothelial Keratoplasty [DSAEK]), patients with hypersensitivity to travoprost or to any other components of the product.

Warnings And Precautions

iDose TR should be used with caution in patients with narrow angles or other angle abnormalities. Monitor patients routinely to confirm the location of the iDose TR at the site of administration. Increased pigmentation of the iris can occur. Iris pigmentation is likely to be permanent.

Adverse Reactions

In controlled studies, the most common ocular adverse reactions reported in 2% to 6% of patients were increases in intraocular pressure, iritis, dry eye, visual field defects, eye pain, ocular hyperaemia, and reduced visual acuity.

Indications And Usage

iDose TR (travoprost intracameral implant) is indicated for the reduction of intraocular pressure (IOP) in patients with open-angle glaucoma (OAG) or ocular hypertension (OHT).

Please see full Prescribing Information.

You are encouraged to report all side effects to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

You may also call Glaukos at 1-888-404-1644.

The information contained in this site is intended for US healthcare professionals only

YES, I AM A US HEALTHCARE PROFESSIONAL NO, I AM NOT A US HEALTHCARE PROFESSIONAL

Request More Info

"*" indicates required fields

By entering this information, you confirm that you are at least 18 years old and that you have read and accept the terms of our Privacy Policy. Glaukos will use the information you provide on this form to provide product updates and other promotional materials. Should you change your mind, you may unsubscribe using the link in the footer of any email you receive from us.

Stay Connected

Sign up to receive the latest information about iDose® TR!

"*" indicates required fields

Glaukos will use the information you provide on this form to get in touch with you.

By entering this information, you confirm that you are at least 18 years old and that you have read and accept the terms of our Privacy Policy. Glaukos will use the information you provide on this form to provide product updates and other promotional materials. Should you change your mind, you may unsubscribe using the link in the footer of any email you receive from us.

This field is for validation purposes and should be left unchanged.